about
Atomic force microscopy images label-free, drug encapsulated nanoparticles in vivo and detects difference in tissue mechanical properties of treated and untreated: a tip for nanotoxicologyExperimental and computational examination of anastellin (FnIII1c)-polymer interactions.Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies.Inclusion of water insoluble drugs in amorphous silica nanoparticles.Encapsulating [FeFe]-hydrogenase model compounds in peptide hydrogels dramatically modifies stability and photochemistry.Gelatine and gelatine/elastin nanocomposites for vascular grafts: processing and characterization.Electrospun collagen-based nanofibres: A sustainable material for improved antibiotic utilisation in tissue engineering applications.Lipid-like self-assembling peptide nanovesicles for drug delivery.Towards scale-up and regulatory shelf-stability testing of curcumin encapsulated polyester nanoparticles.Influence of cholesterol on liposome stability and on in vitro drug release.Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles.Interaction and destabilization of a monoclonal antibody and albumin to surfaces of varying functionality and hydrophobicity.Chitosan derivatives alter release profiles of model compounds from calcium phosphate implants.Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles.A novel methodology to study polymodal particle size distributions produced during continuous wet granulation.Understanding the compaction behaviour of low-substituted HPC: macro, micro, and nano-metric evaluations.Structural hierarchy of biomimetic materials for tissue engineered vascular and orthopedic grafts.Correction to Thermoresponsive Polymer Micropatterns Fabricated by Dip-Pen Nanolithography for a Highly Controllable Substrate with Potential Cellular Applications.Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment.3D printing applications for transdermal drug delivery.Microfluidic manufacturing of phospholipid nanoparticles: Stability, encapsulation efficacy, and drug release.Fabrication and characterisation of drug-loaded electrospun polymeric nanofibers for controlled release in hernia repair.Interplay between Vacuum-Grown Monolayers of Alkylphosphonic Acids and the Performance of Organic Transistors Based on Dinaphtho[2,3-b:2',3'-f]thieno[3,2-b]thiophene.Thermoresponsive Polymer Micropatterns Fabricated by Dip-Pen Nanolithography for a Highly Controllable Substrate with Potential Cellular Applications.Investigation of an 11mm diameter twin screw granulator: Screw element performance and in-line monitoring via image analysis.Inkjet printing of insulin microneedles for transdermal delivery.3D printed microneedles for insulin skin deliveryCo-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer managementStimuli Responsive Polymeric Systems for Cancer TherapyDramatic Specific-Ion Effect in Supramolecular HydrogelsA Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell LinesImplication of linker length on cell cytotoxicity, pharmacokinetic and toxicity profile of gemcitabine-docetaxel combinatorial dual drug conjugateScaling of continuous twin screw wet granulationEnzymatically activated emulsions stabilised by interfacial nanofibre networksA novel hot-melt extrusion formulation of albendazole for increasing dissolution propertiesSustained and controlled release of lipophilic drugs from a self-assembling amphiphilic peptide hydrogelSirolimus Encapsulated Liposomes for Cancer Therapy: Physicochemical and Mechanical Characterization of Sirolimus Distribution within Liposome BilayersCisplatin-Tethered Gold Nanoparticles That Exhibit Enhanced Reproducibility, Drug Loading, and Stability: a Step Closer to Pharmaceutical Approval?Development of Solid Lipid Nanoparticles for Enhanced Solubility of Poorly Soluble Drugs
P50
Q28533356-B58C015E-84E5-403A-92EE-3B7320D1CECFQ36172747-A2F418BE-139D-410B-BCE1-929178937708Q38850497-BA942B64-E4FF-4D9F-A285-6C34BAD23A14Q38865422-0CD0B9F8-0E77-47C0-9945-64D518B91852Q39304272-53F65C16-A0E8-40D9-A9B9-B3130A388C89Q39550641-4EC1FAAA-91B8-46D6-9607-FBC642400186Q39690035-51E6558D-0144-4583-8816-A48BF1F8814BQ40093848-B1976438-2C8A-4074-B2C0-9BFE7C9F4692Q40758645-D2A81921-74C3-4D93-854B-DFE98B491EE0Q41195833-AF16E418-21B4-43C9-90C6-9ED38395C721Q41196425-91BB0525-DC84-4E89-B45C-5889AB357BA3Q43448563-0A5787A4-5625-4367-9F52-C33A7DD7A21BQ45901495-2B1F5256-87AE-4FDE-8DE6-A2994A27E47FQ46082424-83CE0629-0617-4C72-828C-331F8A50E4DFQ46841251-1BCBEC0D-E641-4763-8AED-84C322CC941BQ47241970-690FDD76-8077-4AD1-ADFF-445F5BC27B98Q47835131-75C24408-7966-4F4C-AD31-4A386082FF04Q48013485-1BE347C6-11D4-4731-8CB2-59BEE78FD3BFQ48190933-D6167139-5738-4A08-A564-80D43247908FQ48696930-34E27515-BBC3-40F2-ADCE-7CDF4B6EB1D9Q49885093-2A32CEC6-EC6F-44B8-A4C8-EC6232805D18Q50215258-FFF99EC5-6ECF-4EEA-9514-88907DD917B5Q51004680-A92DB47B-FF1A-45EB-B898-E1CED1F61337Q51177096-A3D79561-C895-4619-A64E-C5CED32CD54CQ51181186-C879C80D-97C7-4A6A-AADA-1D086D3DD5CBQ51714944-82CF8E23-F5A0-49F7-92E0-D29C6D6FA65DQ51821412-658CC3D9-EBDB-424C-96F5-707EC788CC32Q57142746-E1B7E89F-AE48-4710-8B5D-901B57D89DEEQ57143824-E78BAE54-A53E-47E9-BC3A-A6A1F7BD4A3AQ57328205-D497C5C1-9191-4CB2-93ED-81E9D4F824EAQ57342469-1740C2A8-17A3-45CC-AAF5-DB425D72962CQ57765044-2C317C43-27DA-402F-858B-80D4A1BA53B9Q57765046-C1C2B939-5C61-4885-9170-F05B93C248A2Q57765076-FF88A37C-40A3-4DD4-97A9-AAD697426267Q57765081-674B545B-6DCA-4CEE-9087-554D4D544AA6Q57765085-D25950F1-0D67-4C10-B88B-25F961FD3721Q57765092-B2E66188-0549-4978-8CE9-41FA1BAB7EC6Q57765105-32FBF6B9-54AE-4965-A0DA-4D09448952C1Q57765114-4977090B-9434-4C98-8CA8-D45B7B710AA6Q57765117-41ECE35A-F4F7-440C-B615-F6F1DD803955
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dimitrios A Lamprou
@ast
Dimitrios A Lamprou
@en
Dimitrios A Lamprou
@es
Dimitrios A Lamprou
@nl
Dimitrios A Lamprou
@sl
type
label
Dimitrios A Lamprou
@ast
Dimitrios A Lamprou
@en
Dimitrios A Lamprou
@es
Dimitrios A Lamprou
@nl
Dimitrios A Lamprou
@sl
prefLabel
Dimitrios A Lamprou
@ast
Dimitrios A Lamprou
@en
Dimitrios A Lamprou
@es
Dimitrios A Lamprou
@nl
Dimitrios A Lamprou
@sl
P108
P1053
C-4546-2014
P106
P2002
LamprouGroup
P21
P31
P3829
P3835
dimitrios-lamprou
P496
0000-0002-8740-1661